MAPK8 and Parkinson disease: Previous research had uncovered that JNK specific inhibitor SP600125 improved behavioral impairment, inhibited apoptosis of dopaminergic neurons, improved dopaminergic synaptic function in PD mice (Wang et al. 2004).